INBX
Inhibrx Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$121.17
−0.89%Leverage
- Debt / equity
- -0.10x
- Net debt / equity
- 2.42x
- Debt / assets
- 0.03x
- Debt / EBITDA
- -0.04x
- Net debt / EBITDA
- 1.06x
Liquidity & coverage
- Current ratio
- 5.07x
- Quick ratio
- 5.07x
- Cash ratio
- 4.75x
- Interest coverage
- -8.21x
- EBITDA / interest
- -7.74x
- Working capital
- $114.1M
Cash & dividend
- FCF / debt
- -24.69x
- Cash flow / debt
- -24.69x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026